Results 81 to 90 of about 1,056,689 (199)
ABSTRACT Dual inherited defects affecting urea cycle function are exceptionally rare. We report the first case, to our knowledge, of the coexistence of argininosuccinic aciduria (ASA) and citrin deficiency (CD). A girl born to consanguineous Tunisian parents presented at 6 months of age with recurrent seizures, vomiting, developmental delay, and severe
Mouna Zribi +6 more
wiley +1 more source
A hepatic enigma: Pediatric presentation of primary biliary cholangitis
Abstract Primary biliary cholangitis (PBC) is a chronic autoimmune condition characterized by destruction of intrahepatic bile ducts, leading to fibrosis and cirrhosis of the liver. It is an extremely rare pediatric disease with very few pediatric cases reported to date. Here, we report the case of a 14‐year‐old female who presented with elevated liver
Sindhura Kasturi +3 more
wiley +1 more source
Two sisters with progressive familial intrahepatic cholestasis [PDF]
A few months after birth two sisters aged 5 and 9 years had developed cholestasis and abnormal liver functions with symptoms including itching and jaundice. The younger sister also developed rickets and clotting disorders.
Porte, R. J. +5 more
core +4 more sources
Metformin activates the HK1–glycolysis–acCoA–H4K16ac–LGR5 axis to promote cholangiocyte regeneration and suppress EMT‐like phenotypes in cholestatic liver fibrosis. Mechanistically, metformin upregulates HK1‐driven glycolysis, increasing acetyl‐CoA availability for H4K16ac enrichment at the Lgr5 promoter, which transcriptionally activates LGR5.
Yingyu Liang +13 more
wiley +1 more source
Intermediate familial intrahepatic cholestasis: phenotypic spectrum within the BRIC-PFIC spectum
In genetic hepatocellular cholestasis, among the spectrum going from benign recurrent intrahepatic cholestasis (BRIC) and profressive familial intrahepatic cholestasis, intermediate phenotypes ...
Nobili, V +8 more
core +1 more source
By shaping the protein corona, lipid composition directs LNP tropism and enables the preferential delivery of a TIMP1‐targeting siRNA to liver macrophages. In a murine model of primary biliary cholangitis, this strategy promoted macrophage reprogramming and attenuated liver fibrosis.
Naths G. Sukubo +15 more
wiley +1 more source
Placebo arms show substantial improvement in cholestatic pruritus, with up to 30% response rate. Estimates differed across outcome instruments, highlighting the importance of endpoint selection and realistic placebo assumptions in future trial design.
Igor Boechat Silveira +8 more
wiley +1 more source
Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis
ABSTRACT Aim Biallelic pathogenic variants in progressive familial intrahepatic cholestasis (PFIC)‐related genes cause severe pediatric cholestasis. However, the clinical significance of heterozygous variants in adult intrahepatic cholestasis remains unclear.
Shunji Hirose +9 more
wiley +1 more source
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis [PDF]
Neonatal cholestasis is a potentially life-threatening condition requiring prompt diagnosis. Mutations in several different genes can cause progressive familial intrahepatic cholestasis, but known genes cannot account for all familial cases.
Plon, Sharon E +28 more
core +1 more source
ABSTRACT Background and Aims Primary sclerosing cholangitis (PSC) is a rare, progressive cholangiopathy for which diagnosis remains challenging because of the absence of disease‐specific markers and the presence of secondary causes of sclerosing cholangitis (SSC) that closely mimic its clinical presentation. Diagnostic uncertainty can delay appropriate
Miki Scaravaglio +20 more
wiley +1 more source

